Assenagon Asset Management S.A. Sells 1,072,255 Shares of Oscar Health, Inc. (NYSE:OSCR)

Assenagon Asset Management S.A. lessened its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 52.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 973,791 shares of the company's stock after selling 1,072,255 shares during the quarter. Assenagon Asset Management S.A. owned 0.40% of Oscar Health worth $20,654,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in OSCR. Vanguard Group Inc. lifted its stake in Oscar Health by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 14,244,912 shares of the company's stock valued at $130,341,000 after buying an additional 116,978 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new position in Oscar Health in the 1st quarter worth $4,117,000. Quantbot Technologies LP increased its holdings in Oscar Health by 435.5% during the 1st quarter. Quantbot Technologies LP now owns 14,495 shares of the company's stock worth $216,000 after purchasing an additional 11,788 shares in the last quarter. Oppenheimer & Co. Inc. raised its stake in shares of Oscar Health by 20.8% in the 1st quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company's stock valued at $289,000 after purchasing an additional 3,350 shares during the period. Finally, Avalon Trust Co bought a new stake in shares of Oscar Health in the first quarter valued at about $69,000. 75.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently issued reports on OSCR. UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective for the company. Piper Sandler reaffirmed an "overweight" rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $24.00.

Oscar Health Stock Down 5.9 %

Shares of NYSE:OSCR traded down $1.01 during trading on Friday, hitting $16.19. 3,674,414 shares of the company were exchanged, compared to its average volume of 3,207,187. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $23.79. The stock has a market cap of $3.84 billion, a price-to-earnings ratio of -40.48, a P/E/G ratio of 31.76 and a beta of 1.62. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The firm has a fifty day moving average price of $18.80 and a two-hundred day moving average price of $18.35.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The business had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same period in the previous year, the company earned ($0.07) earnings per share. The firm's revenue for the quarter was up 44.6% on a year-over-year basis. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Richard Scott Blackley sold 68,978 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares of the company's stock, valued at $15,906,991.87. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, CFO Richard Scott Blackley sold 68,978 shares of the firm's stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the completion of the sale, the chief financial officer now owns 884,213 shares in the company, valued at approximately $15,906,991.87. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Victoria Baltrus sold 4,226 shares of the company's stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the transaction, the chief accounting officer now owns 140,648 shares in the company, valued at approximately $2,530,257.52. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is owned by company insiders.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.